Is NexgenRx Inc. (NEGXF) a Buy, Sell, or Hold?
OTC : NEGXF
NexgenRx Inc. — News
$0.325 USD
$0 (0.0%)
- Volume
- 23K
- Average Volume
- 786
- Market Capitalization
- $23.11M
- P/E Ratio
- 18.10
- Dividend Yield
- 3.35%
- Price Target
- Year High
- $0.33
- Year Low
- $0.20
- Day High
- —
- Day Low
- —
- Payout Ratio
- $0.65
- Current Ratio
- $1.16
| Source | Headline |
|---|---|
|
NexgenRx Announces Solid Q1 2026 Results with Continued Increasing Revenue, Net Income and EBITDA Growth
TORONTO, ON / ACCESS Newswire / May 21, 2026 / NEXGENRX INC. ("NexgenRx" or the "Company") is pleased to announce its financial results for the first quarter ended March 31, 2026, with net income of $1,228,288 and EBITDA of $1,444,036, representing increases of $701,078 and $615,635, respectively, compared to the same period in 2025. accessnewswire.com - 2026-05-21 20:15:00 |
